Bench-to-bedside investigations of H3 K27-altered diffuse midline glioma: drug targets and potential pharmacotherapies-Reference-Cited by-同舟云学术

Bench-to-bedside investigations of H3 K27-altered diffuse midline glioma: drug targets and potential pharmacotherapies

Published:2023-11-02 Issue:11 Volume:27 Page:1071-1086
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Rechberger Julian S.¹²,Bouchal Samantha M.¹²,Power Erica A.³,Nonnenbroich Leo F.¹⁴⁵,Nesvick Cody L.¹,Daniels David J.¹²

Affiliation:

1. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA

2. Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, USA

3. Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA

4. Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany

5. Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2023.2277232

Reference128 articles.

1. Cancer Statistics, 2021

2. CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018

3. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries

4. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019

5. Brainstem Glioma: A Review

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T cells for H3K27-altered diffuse midline gliomas: where do we stand?;Immunotherapy;2024-07-17

2. H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions;Cells;2024-06-28